Inhibition of carcinoma cell growth and metastasis by a vesicular stomatitis virus G-pseudotyped retrovector expressing type I insulin-like growth factor receptor antisense

Human Gene Therapy

Volumn 12, Issue 16, 2001, Pages 1969-1977

  Samani, A A ^a   Fallavollita, L ^a   Jaalouk, D E ^a   Galipeau, J ^a   Brodt, P ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; GREEN FLUORESCENT PROTEIN; SOMATOMEDIN C RECEPTOR; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE THERAPY; GENETIC TRANSDUCTION; LIVER METASTASIS; LONG TERMINAL REPEAT; MITOSIS INHIBITION; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; RAT; VESICULAR STOMATITIS VIRUS;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL DIVISION; FEMALE; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM METASTASIS; OLIGONUCLEOTIDES, ANTISENSE; RECEPTOR, IGF TYPE 1; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; VIRAL ENVELOPE PROTEINS;

ANIMALIA; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; ONCOVIRINAE; VESICULAR STOMATITIS VIRUS;

EID: 0035195965     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401753204544     Document Type: Article

References (32)

1. Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice
2. Controlling IGF-receptor function: A possible strategy for tumor therapy
3. The IGF-I receptor in cancer research
4. Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities
5. Inhibition of the type I insulin-like growth factor receptor expression and signaling: Novel strategies for antimetastatic therapy
6. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
7. Insulin-like growth factor binding proteins localize to discrete cell culture compartments in periosteal and osteoblast cultures from fetal rat bone
8. Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action
9. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism
10. Characterization, regulation, and function of specific cell membrane receptors for insulin-like growth factor I on bone endothelial cells
11. Vesicular stomatitis virus G pseudo-typed retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer
12. Expression of insulin-like growth factor-1 receptor in human colorectal cancer
13. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer
14. Gene therapy for the treatment of metastatic breast cancer by in vivo transduction with breast-targeted retroviral vector expressing antisense c-fos RNA
15. Glucocorticoid-inducible retrovector for regulated transgene expression in genetically engineered bone marrow stromal cells
16. The insulin-like growth factor axis and prostate cancer: Lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model
17. Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma
18. Proteinolytic activity against IGF-binding proteins involved in the paracrine interactions between prostate adenocarcinoma cells and osteoblasts
19. Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: A regulatory mechanism for carcinoma cells metastatic to the liver
20. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor
21. r 72, 000 type IV collagenase by the type I insulin-like growth factor receptor
22. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
23. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
24. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
25. Inhibition of endosomal insulin-like growth factor-1 processing by cysteine proteinase inhibitors blocks receptor-mediated functions
26. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
27. The receptor for the type I insulin-like growth factor and its ligands regulate multiple cellular functions that impact on metastasis
28. Immune response to green fluorescent protein: Implications for gene therapy
29. Correlation of glioma cell regression with inhibition of insulin-like growth factor 1 and insulin-like growth factor-binding protein-2 expression
30. Suppression of TGF-beta1 in human gliomas by retroviral gene transfection enhances susceptibility to LAK cells
31. Antisense bcl-2 retrovirus vector increases the sensitivity of a human gastric adenocarcinoma cell line to photodynamic therapy
32. Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype